Medical device maker Medtronic to buy CathWorks in up to $585 million deal
Medtronic said on Tuesday it would buy privately held CathWorks in a deal valued at up to $585 million, as it looks to bolster its heart devices portfolio by adding a new diagnostic tool that could improve care standards.
Why the Market Dipped But Medtronic (MDT) Gained Today
In the closing of the recent trading day, Medtronic (MDT) stood at $102.96, denoting a +1.94% move from the preceding trading day.
3 Reasons to Add This Medical Technology Stock to Your Portfolio in 2026
Medtronic is divesting a business that's slowing down its margins. The company entered an important market last year.
Medtronic plc (MDT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Medtronic plc (MDT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Medtronic has 'significant firepower' for multiple acquisitions, executives say
Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off on Monday in San Francisco.
MDT or ESLOY: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Products sector might want to consider either Medtronic (MDT) or EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks presents investors with the better value opportunity right now?
The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & Johnson
Eli Lilly highlights how AI is transforming healthcare, from drug discovery to diagnostics, turning defensive medical stocks into growth plays for 2026.
MDT vs. ESLOY: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both Medtronic (MDT) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks offers value investors a better bang for their buck right now?
MiniMed Group Files For IPO In Medtronic Carve-Out
MiniMed Group, Inc., a Medtronic subsidiary, is targeting an IPO to fund growth and working capital amid diabetes device market expansion. MMED is well-positioned in automated insulin delivery, boasting an integrated product stack, strong recurring revenue, and international reach. Financials show rising revenue and gross profit, but operating leverage remains limited due to high R&D and pending clarity on intercompany debt repayment.
Medtronic: A Defensive Gem For Uncertain Times
Medtronic plc exemplifies a 'wonderful company at a fair price,' trading near its calculated DCF fair value of $98 per share. MDT demonstrates nearly three decades of resilient revenue growth, high margins, and robust shareholder yield, underscoring its defensive investment appeal. The company boasts a 49-year dividend growth streak and has returned 42.2% of market cap to shareholders via buybacks and dividends over the past decade.
Medtronic Spin-Off MiniMed Files for IPO
Medtronic will own at least 80.1% of the voting stock for MiniMed once the IPO is complete.
Why Is Medtronic (MDT) Down 2% Since Last Earnings Report?
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
